Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hohlfeld

Showing results (91-100 of 206) with videos related to

Pageof 21
Sort By:
MMW Fortschritte Der Medizin|June 20, 2002
[Multiple sclerosis. Therapeutic nihilism is the wrong approach here]R Voltz, N Goebels, S Jarius, et al.
Immunology Today|June 1, 1995
T-cell autoimmunity in multiple sclerosisR Hohlfeld, M Londei, L Massacesi, et al.
Lancet (London, England)|March 21, 1992
Gardener's mydriasisR Voltz, R Hohlfeld, M Liebler, et al.
Der Nervenarzt|September 21, 2000
[Multiple sclerosis. Current review of failed and discontinued clinical trials of drug treatment]H Wiendl, O Neuhaus, L Kappos, et al.
Klinische Wochenschrift|July 15, 1987
A reliable method for immunocytochemical characterization of CSF cellsR Hohlfeld, W Johanns, A Fahsbender, et al.
Journal of Neuroimmunology|May 26, 1998
T-cell heterogeneity in muscle lesions of inclusion body myositisA Bender, L Behrens, A G Engel, et al.
The Journal of Experimental Medicine|December 1, 1992
Autoaggressive myocytotoxic T lymphocytes expressing an unusual gamma/delta T cell receptorG Pluschke, D Rüegg, R Hohlfeld, et al.
Der Nervenarzt|February 10, 2006
[Pregnancy and immunomodulatory therapy in multiple sclerosis patients]L A Hoffmann, T Kümpfel, I Heer, et al.
Brain : a Journal of Neurology|June 1, 1997
Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cellsL Behrens, A Bender, M A Johnson, et al.
Current Opinion in Rheumatology|February 12, 1998
Cellular immune mechanisms in inflammatory myopathiesR Hohlfeld, A G Engel, N Goebels, et al.
Pageof 21

Showing results (91-100 of 206) with videos related to

Sort By:
Pageof 21
MMW Fortschritte Der Medizin|June 20, 2002
[Multiple sclerosis. Therapeutic nihilism is the wrong approach here]R Voltz, N Goebels, S Jarius, et al.
Immunology Today|June 1, 1995
T-cell autoimmunity in multiple sclerosisR Hohlfeld, M Londei, L Massacesi, et al.
Lancet (London, England)|March 21, 1992
Gardener's mydriasisR Voltz, R Hohlfeld, M Liebler, et al.
Der Nervenarzt|September 21, 2000
[Multiple sclerosis. Current review of failed and discontinued clinical trials of drug treatment]H Wiendl, O Neuhaus, L Kappos, et al.
Klinische Wochenschrift|July 15, 1987
A reliable method for immunocytochemical characterization of CSF cellsR Hohlfeld, W Johanns, A Fahsbender, et al.
Journal of Neuroimmunology|May 26, 1998
T-cell heterogeneity in muscle lesions of inclusion body myositisA Bender, L Behrens, A G Engel, et al.
The Journal of Experimental Medicine|December 1, 1992
Autoaggressive myocytotoxic T lymphocytes expressing an unusual gamma/delta T cell receptorG Pluschke, D Rüegg, R Hohlfeld, et al.
Der Nervenarzt|February 10, 2006
[Pregnancy and immunomodulatory therapy in multiple sclerosis patients]L A Hoffmann, T Kümpfel, I Heer, et al.
Brain : a Journal of Neurology|June 1, 1997
Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cellsL Behrens, A Bender, M A Johnson, et al.
Current Opinion in Rheumatology|February 12, 1998
Cellular immune mechanisms in inflammatory myopathiesR Hohlfeld, A G Engel, N Goebels, et al.
Pageof 21